These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2558361)

  • 1. Recovery of VIP/helodermin- and prostaglandin E1-stimulated adenylate cyclase activities in desensitized SUP-T1 human lymphoblasts.
    Robberecht P; De Neef P; Abello J; Damien C; Coussaert E; Christophe J
    Peptides; 1989; 10(5):1027-31. PubMed ID: 2558361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP receptors in human SUP-T1 lymphoblasts.
    Christophe J; Cauvin A; Vervisch E; Buscail L; Damien C; Abello J; Gourlet P; Robberecht P
    Digestion; 1990; 46 Suppl 2():148-55. PubMed ID: 1979777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
    Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line.
    Robberecht P; De Neef P; Waelbroeck M; Tastenoy M; Christophe J
    Peptides; 1989; 10(2):441-6. PubMed ID: 2474155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
    Robberecht P; De Neef P; Gourlet P; Cauvin A; Coy DH; Christophe J
    Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization and recovery of prostaglandin-stimulated adenylate cyclase activity in a murine virus-induced T lymphoma cell line BL/VL3.
    Abello J; Robberecht P; Damien C; Christophe J
    J Recept Res; 1989-1990; 9(6):451-63. PubMed ID: 2640473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
    Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased adenylate cyclase activation by helodermin and PGE1 in the lectin-resistant variant Wa4 of the mouse melanoma cell line B16.
    Damien C; Robberecht P; Hooghe R; De Neef P; Christophe J
    Peptides; 1989; 10(5):1075-9. PubMed ID: 2558362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of helodermin-preferring VIP receptors in SUP T1 lymphoma cells: evidence for receptor glycosylation.
    Gourlet P; Robberecht P; Christophe J
    J Recept Res; 1991; 11(5):831-48. PubMed ID: 1656036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
    Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
    Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
    Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
    Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J; Damien C; Robberecht P; Hooghe R; Vandermeers A; Vandermeers-Piret MC; Christophe J
    Eur J Biochem; 1989 Aug; 183(2):269-74. PubMed ID: 2547607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP and PGE1 activate adenylate cyclase in rat intestinal epithelial cell membranes via different mechanisms.
    Beubler E
    Eur J Pharmacol; 1981 Aug; 74(1):67-72. PubMed ID: 7198581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP-helodermin receptors in the murine virus-induced T lymphoma cell line BL/VL3 recover less rapidly than beta-adrenoceptors after down regulation.
    Damien C; Robberecht P; Abello J; Hooghe R; Christophe J
    J Recept Res; 1989-1990; 9(6):441-9. PubMed ID: 2561794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG; Neal DE; Simmons NL
    J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin receptors in human pancreatic membranes.
    Robberecht P; De Neef P; Waelbroeck M; Camus JC; Scemama JL; Fourmy D; Pradayrol L; Vaysse N; Christophe J
    Pancreas; 1988; 3(5):529-35. PubMed ID: 3186683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector mechanisms of peptides of the VIP family.
    Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P
    Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.